Form 4: Thermo Fisher Scientific Director Nelson Chai Reports Transactions in Company Stock

Director Nelson Chai disclosed several transactions involving Thermo Fisher Scientific Inc. common stock, including purchases and sales, executed through a broker-managed account.

Summary

• Nelson Chai, a director of Thermo Fisher Scientific Inc., reported changes in beneficial ownership of the company's common stock.
• On November 7, 2024, Chai purchased 16 shares at $555.89 per share.
• On December 9, 2024, Chai purchased 4 shares at $535.9326 per share.
• On February 19, 2025, Chai sold 16 shares at $528.09 per share.
• Following these transactions, Chai directly owns 14,252 shares of Thermo Fisher Scientific Inc. common stock.
• The transactions were inadvertently executed by a broker through a broker-managed account without Chai's direct instruction or knowledge.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by a director. The transactions themselves are described as inadvertent, minimizing any potential signal.

Management Comments

• The transactions were inadvertently effected by a broker through a broker managed account without any instruction from or knowledge of the reporting person.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The reported transactions may have a minor impact on shareholder sentiment, but are unlikely to significantly affect the company's operations or financial performance.

Key Dates

Keywords

Thermo Fisher Scientific, Nelson Chai, Stock Transactions, Beneficial Ownership, Form 4, TMO, Director